Qube Research & Technologies (QRT)’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Sell
91,300
-53,300
-37% -$10.6M 0.02% 940
2026
Q1
$23.8M Sell
144,600
-152,300
-51% -$26.4M 0.03% 785
2025
Q4
$52.7M Buy
296,900
+32,200
+12% +$5.37M 0.05% 467
2025
Q3
$42.1M Sell
264,700
-244,900
-48% -$36.2M 0.04% 540
2025
Q2
$71.8M Buy
509,600
+138,900
+37% +$17.1M 0.07% 352
2025
Q1
$43.2M Buy
370,700
+295,500
+393% +$38.1M 0.05% 459
2024
Q4
$9.45M Buy
75,200
+11,600
+18% +$1.43M 0.01% 1127
2024
Q3
$6.63M Sell
63,600
-300,300
-83% -$30.2M 0.01% 1256
2024
Q2
$35.4M Sell
363,900
-90,800
-20% -$8.64M 0.06% 405
2024
Q1
$42.8M Sell
454,700
-23,300
-5% -$2.05M 0.07% 341
2023
Q4
$44.6M Buy
478,000
+211,200
+79% +$16.9M 0.09% 290
2023
Q3
$21.8M Buy
+266,800
New +$23.2M 0.06% 396

Other funds holding MS

Qube Research & Technologies (QRT)'s MS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Morgan Stanley (MS) stake by 33% in Q2 2026, buying an estimated $69.3M and bringing the position to 1,424,082 shares worth $298M. The position accounts for 0.28% of the portfolio, ranked #71.

Qube Research & Technologies (QRT) first reported a position in MS in Q1 2018 and has held it in 28 quarters since. The position peaked at $347M in Q4 2025. 2,739 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,424,082 shares of Morgan Stanley worth $298M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 349,748 Morgan Stanley shares in Q2 2026, an estimated $69.3M.
  • Morgan Stanley made up 0.28% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #71 holding.
  • Qube Research & Technologies (QRT) first reported a position in Morgan Stanley in Q1 2018 and has held it in 28 quarters since.
  • Qube Research & Technologies (QRT)'s Morgan Stanley position peaked at $347M in Q4 2025.
  • 2,739 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.